C G Goetz

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. request reprint
    Goetz C, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord. 2005;20:523-39 pubmed
    ..We consider a 3-year period a reasonable time frame for published updates and are working to establish a Web-based mechanism to update the report in an ongoing manner. ..
  2. Goetz C, Tilley B, Shaftman S, Stebbins G, Fahn S, Martinez Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129-70 pubmed publisher
    ..90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD. ..
  3. request reprint
    Goetz C. Poor Beard!! Charcot's internationalization of neurasthenia, the "American disease". Neurology. 2001;57:510-4 pubmed
    ..Adding neurasthenia to the other neurologic descriptions from the United States by Hammond, Mitchell, and Dana, Charcot helped to foster the recognition of the American Neurologic School. ..
  4. request reprint
    Goetz C. J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies. Neurology. 2007;69:103-9 pubmed
    ..His diagnostic techniques are echoed by contemporary approaches and emphasized an attention to enhanced and inconsistent patterns of behaviors by malingerers. ..
  5. Goetz C. New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease. Mov Disord. 2010;25 Suppl 1:S104-9 pubmed publisher
    ..New treatments are being developed, but there have been very few large-scale randomized clinical trials to test the relative roles of new or available agents for abating these problematic behaviors. ..
  6. Goetz C. Charcot, hysteria, and simulated disorders. Handb Clin Neurol. 2016;139:11-23 pubmed publisher
    ..He developed specific experimental techniques to separate hysteria from simulation. His studies of hysteria and simulation offer a basis for studies of functional neurologic disorders applicable to the 21st century. ..
  7. Goetz C, Nutt J, Stebbins G. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile. Mov Disord. 2008;23:2398-403 pubmed publisher
    ..The UDysRS is a clinimetrically sound rating scale for dyskinesia in PD, demonstrating acceptable levels of internal consistency and inter- and intra-rater reliability. Testing scale responsivity to treatment interventions is planned...
  8. Goetz C, Stebbins G, Wolff D, DeLeeuw W, Bronte Stewart H, Elble R, et al. Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device. Mov Disord. 2009;24:551-6 pubmed publisher
    ....

Locale

Collaborators

Detail Information

Publications8

  1. request reprint
    Goetz C, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord. 2005;20:523-39 pubmed
    ..We consider a 3-year period a reasonable time frame for published updates and are working to establish a Web-based mechanism to update the report in an ongoing manner. ..
  2. Goetz C, Tilley B, Shaftman S, Stebbins G, Fahn S, Martinez Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129-70 pubmed publisher
    ..90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD. ..
  3. request reprint
    Goetz C. Poor Beard!! Charcot's internationalization of neurasthenia, the "American disease". Neurology. 2001;57:510-4 pubmed
    ..Adding neurasthenia to the other neurologic descriptions from the United States by Hammond, Mitchell, and Dana, Charcot helped to foster the recognition of the American Neurologic School. ..
  4. request reprint
    Goetz C. J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies. Neurology. 2007;69:103-9 pubmed
    ..His diagnostic techniques are echoed by contemporary approaches and emphasized an attention to enhanced and inconsistent patterns of behaviors by malingerers. ..
  5. Goetz C. New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease. Mov Disord. 2010;25 Suppl 1:S104-9 pubmed publisher
    ..New treatments are being developed, but there have been very few large-scale randomized clinical trials to test the relative roles of new or available agents for abating these problematic behaviors. ..
  6. Goetz C. Charcot, hysteria, and simulated disorders. Handb Clin Neurol. 2016;139:11-23 pubmed publisher
    ..He developed specific experimental techniques to separate hysteria from simulation. His studies of hysteria and simulation offer a basis for studies of functional neurologic disorders applicable to the 21st century. ..
  7. Goetz C, Nutt J, Stebbins G. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile. Mov Disord. 2008;23:2398-403 pubmed publisher
    ..The UDysRS is a clinimetrically sound rating scale for dyskinesia in PD, demonstrating acceptable levels of internal consistency and inter- and intra-rater reliability. Testing scale responsivity to treatment interventions is planned...
  8. Goetz C, Stebbins G, Wolff D, DeLeeuw W, Bronte Stewart H, Elble R, et al. Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device. Mov Disord. 2009;24:551-6 pubmed publisher
    ....